Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 6—June 2007

Perspective

Economic Evaluation and Catheter-related Bloodstream Infections

Kate Halton*†Comments to Author  and Nicholas Graves*†
Author affiliations: *The Centre for Healthcare Related Infection Surveillance and Prevention, Brisbane, Queensland, Australia; †Queensland University of Technology, Brisbane, Queensland, Australia

Main Article

Table 6

Ranks of evidence for parameters used in the decision models*

Evidence ranking Clinical effectiveness of intervention, n = 8 Baseline incidence 
CR-BSI, n = 8 Attributable mortality,
n = 7 Incidence localized insertion site infection, n = 5 Cost of 
CR-BSI, 
n = 8 Cost of intervention, n n = 8
High quality
  Rank 1 5 1 2
  Rank 2 1 1 1 1 7
Medium quality
  Rank 3 1 1 2
Low quality
  Rank 4 1 4 4 4 2
  Rank 5 1 1 1
  Rank 6
Unclear 1 1 1

*CR-BSI, catheter-related bloodstream infections.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO